Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Jason, T.L.; Figueredo, R.; Ferguson, P.J.; Vincent, M.D.; Berg, R.W.; Koropatnick, J.
    ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines (2008), DNA Cell Biol., 27, 229-240.
    View publication on PubMed

Inhibitors

EC Number Inhibitors Comment Organism Structure
2.1.1.45 5-fluorodeoxyuridine
-
 Homo sapiens
2.1.1.45 raltitrexed
-
 Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
2.1.1.45 Homo sapiens
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
2.1.1.45 HeLa cell
-
 Homo sapiens
-
2.1.1.45 HT-29 cell
-
 Homo sapiens
-
2.1.1.45 MCF-7 cell
-
 Homo sapiens
-
2.1.1.45 MDA-MB-231 cell
-
 Homo sapiens
-
2.1.1.45 MSTO-211H cell
-
 Homo sapiens
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2.1.1.45 5,10-methylenetetrahydrofolate + 6-fluoro-dUMP
-
 Homo sapiens ?
-
 ?
2.1.1.45 5,10-methylenetetrahydrofolate + dUMP
-
 Homo sapiens dihydrofolate + dTMP
-
 ?

Cofactor

EC Number Cofactor Comment Organism Structure
2.1.1.45 N5,N10-methylenetetrahydrofolate
-
 Homo sapiens

Expression

EC Number Organism Comment Expression
2.1.1.45 Homo sapiens thymidylate synthase antisense oligodeoxynucleotide (ODN) 491 decreases thymidylate protein levels in HeLa cells with a concomitant increase in sensitivity to thymidylate synthase-targeting chemotherapeutics. In MCF-7 cells, ODN491 treatment is less effective at reducing thymidylate synthase mRNA and does not reduce thymidylate synthase protein, nor does it enhance sensitivity to thymidylate synthase-targeting or other chemotherapeutics. Treatment with either ODN 83 or ODN 491 reduces 6-fluoro-dUMP binding in HeLa cells by 59% and 62%, respectively, compared with control down